Leucine Rich Bio launches Rychbiome Balancing Cream and BugSpeaks Skin Test, pioneering microbiome-based skincare with daily care and personalised scientific analysis for healthier, hydrated, and resilient skin.
Leucine Rich Bio, South Asia’s trailblazer in microbiome science, has announced a double breakthrough in skin health. It has launched the Rychbiome Microbiome Balancing Cream and the BugSpeaks Facial Skin Microbiome Test. Together, these innovations mark a significant step toward personalised, microbiome-focused skincare that addresses both the root causes and visible signs of skin concerns.
Rychbiome Microbiome Balancing Cream
The Rychbiome Microbiome Balancing Cream is designed to nurture the skin’s natural ecosystem rather than simply treating its surface. It’s infused with probiotic lysate, prebiotic botanicals, and skin-nourishing actives. The cream supports skin health by improving and restoring skin microbial balance. Ultimately, it helps enrich hydration and strengthen the skin barrier.
Key benefits include:
- Restoring microbiome harmony to minimise redness, sensitivity, and breakouts
- Delivering deep hydration and barrier protection, ideal for dry or reactive skin
- Boosting elasticity and smoothing fine lines through probiotic-enriched hydration
- Calming irritation with gentle, natural ingredients
Suitable for all skin types and recommended for daily use, Rychbiome aligns with Leucine Rich Bio’s mission of microbiome-based wellness by supporting the skin’s ecosystem from within.
What the leadership says about the cream
Mr. Prabhath Manjappa, Co-founder and CPO of Leucine Rich Bio, said, “Our skin is its own microbiome ecosystem, and we cannot ignore its microbial harmony. Rychbiome is a breakthrough, the first cream in India built on microbiome science, designed to recalibrate and support skin from the microbial level, not just the surface.”
BugSpeaks Facial Skin Microbiome Test
Complementing the cream’s topical care, the BugSpeaks Facial Skin Microbiome Test provides a science-backed roadmap to healthier skin. This test analyses the millions of beneficial microorganisms living on the skin’s surface. These are vital defenders that protect against pathogens, regulate immune responses, and promote healing.
The test follows a four-step process of quality control, DNA sequencing, data analysis, and report verification. BugSpeaks evaluates critical parameters such as hydration, elasticity, aging, and barrier strength. Customers receive a personalised, algorithm-generated report offering recommendations for topical ingredients, diet, lifestyle, and probiotics to restore balance and resilience.
What the leadership says about the test
Dr Debojyoti Dhar, Co-Founder and Director, says “We took some time in bringing our next microbiome profiling test targeting skin after gut, as we wanted to bring in more actionable parameters in the report. It is an attempt to translate the microbiome science into something that will impact the well-being of individuals by maintaining good skin health!”
Kumar Sankaran, CEO, opines, “BugSpeaks skin microbiome test can revolutionize the skin healthcare market. We believe this will also help propagate the importance of the microbes in our wellbeing”
Meeting a growing global demand
The launches arrive as the global skin microbiome market stands at a valuation of USD 1.03 billion in 2024. It is likely to nearly triple by 2032. With rising awareness and disposable incomes, the Middle East and GCC are poised as key markets.
Leucine Rich Bio reinforces its credibility with ISO 9001:2015 and ISO/IEC 17025 certifications, along with NABH and NABL accreditations, ensuring the highest laboratory and clinical standards.
By introducing both Rychbiome and the BugSpeaks Skin Test, Leucine Rich Bio sets a new benchmark in microbiome-driven skincare, offering consumers an integrated approach to lasting skin health.